{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:43:28Z","timestamp":1793447008781,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tianjin Natural Science General","award":["2018KJ124"],"award-info":[{"award-number":["2018KJ124"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejmech.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:57:45Z","timestamp":1546977465000},"page":"640-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":540,"special_numbering":"C","title":["Composition design and medical application of liposomes"],"prefix":"10.1016","volume":"164","author":[{"given":"Mingyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuou","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-6046","authenticated-orcid":false,"given":"Xin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9920-6778","authenticated-orcid":false,"given":"Hua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Galons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.01.007_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2011.11.010","article-title":"Enhanced permeability and retention effect for selective targeting of anti-cancer nanomedicine: are we there yet?","volume":"9","author":"Greish","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib3","unstructured":"WHO | Cancer, WHO (n.d.) http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/(Accessed 07\/06\/2018)."},{"key":"10.1016\/j.ejmech.2019.01.007_bib4","first-page":"68","article-title":"Renal toxicities of chemotherapy, Semin","volume":"33","author":"Jonge","year":"2006","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.10201","article-title":"TLC D-99 study group, liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma","volume":"94","author":"Harris","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2019.01.007_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib7","first-page":"6387","article-title":"A\u00a0new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.01.007_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.01.007_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in\u00a0vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib11","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness","volume":"156","author":"Hashizume","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A\u00a0review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1259\/0007-1285-58-685-35","article-title":"Technetium-labelled liposome imaging for deep-seated infection","volume":"58","author":"Morgan","year":"1985","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib14","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2019.01.007_bib15","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/j.bmcl.2011.04.071","article-title":"The synthesis of cholesterol-based cationic lipids with trimethylamine head and the effect of spacer structures on transfection efficiency","volume":"21","author":"Kim","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.007_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2174\/0929867033457476","article-title":"Structure-activity relationship in cationic lipid mediated gene transfection","volume":"10","author":"Niculescu-Duvaz","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.007_bib18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in\u00a0vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.01.007_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1021\/acs.molpharmaceut.5b00967","article-title":"Specially-made lipid-based assemblies for improving transmembrane gene delivery: comparison of basic amino acid residue rich periphery","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.01.007_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0168-3659(99)00158-3","article-title":"Synthesis of a single-tailed cationic lipid and investigation of its transfection","volume":"62","author":"Tang","year":"1999","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/acs.molpharmaceut.6b01006","article-title":"Therapeutic efficacy of cisplatin thermosensitive liposomes upon mild hyperthermia in C26 tumor bearing BALB\/c mice","volume":"14","author":"Alavizadeh","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.01.007_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/mp8002573","article-title":"Hydrophobic moiety of cationic lipids strongly modulates their transfection activity","volume":"6","author":"Koynova","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.01.007_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2011.01.051","article-title":"Gene transfer efficacies of serum-resistant amino acids-based cationic lipids: dependence on headgroup, lipoplex stability and cellular uptake","volume":"408","author":"Li","year":"2011","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ejmech.2019.01.007_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biochi.2018.06.011","article-title":"Corticoids modulate liposome membrane fluidity and permeability depending on membrane composition and experimental protocol design","volume":"153","author":"Kaddah","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2019.01.007_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/bc000081o","article-title":"New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity","volume":"12","author":"Choi","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2019.01.007_bib26","first-page":"144","article-title":"Toxicity of cationic lipid\u2013ribozyme complexes in human prostate tumor cells can mimic ribozyme activity","volume":"59","author":"Freedland","year":"1996","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0005-2736(90)90017-I","article-title":"Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles","volume":"1023","author":"Rania","year":"1990","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.ejmech.2019.01.007_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/bbrc.1997.7923","article-title":"Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA","volume":"242","author":"Fuxing","year":"1998","journal-title":"Biochem. Biophys. Res. CO"},{"key":"10.1016\/j.ejmech.2019.01.007_bib29","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1021\/am502579e","article-title":"pH- and reduction-responsive polymeric lipid vesicles for enhanced tumor cellular internalization and triggered drug release","volume":"6","author":"Wang","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejmech.2019.01.007_bib30","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/cmdc.201500381","article-title":"pH-cleavable nucleoside lipids: a new paradigm for controlling the stability of lipid-based delivery systems","volume":"10","author":"Oumzil","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.01.007_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11745-005-1446-5","article-title":"Synthesis and characterization of a series of carbamate-linked cationic lipids for gene delivery","volume":"40","author":"Liu","year":"2005","journal-title":"Lipids"},{"key":"10.1016\/j.ejmech.2019.01.007_bib32","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1021\/jm0408159","article-title":"Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties","volume":"47","author":"Aissaoui","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.007_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0304-4165(81)90259-2","article-title":"Interactions of liposomes with the reticuloendothelial system effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles","volume":"677","author":"Kao","year":"1981","journal-title":"BBA-Gen. Subj."},{"key":"10.1016\/j.ejmech.2019.01.007_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0169-409X(95)00028-6","article-title":"Sterically stabilized liposome therapeutics","volume":"16","author":"Woodle","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0005-2736(90)90440-Y","article-title":"Liposomes for the sustained drug release in\u00a0vivo","volume":"1029","author":"Blume","year":"1990","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.ejmech.2019.01.007_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2019.01.007_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-4157(92)90038-C","article-title":"Sterically stabilized liposomes","volume":"1113","author":"Woodle","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.01.007_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.colsurfb.2018.08.022","article-title":"PEGylated liposomes as delivery systems for Gambogenic acid: characterization and in\u00a0vitro\/in\u00a0vivo evaluation","volume":"172","author":"Tang","year":"2018","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejmech.2019.01.007_bib40","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0031-6997(24)01426-1","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors","volume":"51","author":"Drummond","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2019.01.007_bib42","article-title":"Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes","author":"Chaoyang","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1208\/s12249-012-9776-5","article-title":"Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity, AAPS","volume":"13","author":"Zhang","year":"2012","journal-title":"Pharm. Sci. Tech."},{"key":"10.1016\/j.ejmech.2019.01.007_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/10611860802229978","article-title":"Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal Doxorubicin in a murine model of HER2-overexpressing breast cancer","volume":"16","author":"Laginha","year":"2008","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.ejmech.2019.01.007_bib45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2009.01.023","article-title":"Targeted delivery of DOXorubicin using stealth liposomes modified with transferrin","volume":"373","author":"Li","year":"2009","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ejmech.2019.01.007_bib46","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0959-8049(03)00273-9","article-title":"Exploiting the hallmarks of cancer: the future conquest of breast cancer","volume":"39","author":"Sledge","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2019.01.007_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1389200217666160619191853","article-title":"Actively targeted nanoparticles for drug delivery to tumor","volume":"17","author":"Bi","year":"2016","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1073\/pnas.72.1.88","article-title":"A\u00a0general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells","volume":"72","author":"Weissmann","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2019.01.007_bib49","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.2147\/IJN.S162454","article-title":"Docetaxel-trastuzumab stealth immunoliposome: development and in\u00a0vitro proof of concept studies in breast cancer","volume":"13","author":"Rodallec","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2019.01.007_bib50","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1748-0132(07)70083-X","article-title":"Targeted nanoparticles for cancer therapy","volume":"2","author":"Frank","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.ejmech.2019.01.007_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2017.12.011","article-title":"Folic acid-modified liposomal drug delivery strategy for tumor targeting of 5-fluorouracil","volume":"114","author":"Moghimipour","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation","volume":"229","author":"Ravar","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2004.02.003","article-title":"Folate receptor targeted biodegradable polymeric doxorubicin micelles","volume":"96","author":"Yoo","year":"2004","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","article-title":"Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma","volume":"277","author":"Jhaveri","year":"2018","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A\u00a0review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin \u03b1v\u03b23 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"Peter","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.01.007_bib57","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/IJN.S157746","article-title":"Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in\u00a0vitro\/vivo evaluation","volume":"13","author":"Jiang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2019.01.007_bib58","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.7150\/thno.23050","article-title":"Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer","volume":"8","author":"Dasa","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2019.01.007_bib59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1748-0132(07)70083-X","article-title":"Targeted nanoparticles for cancer therapy","volume":"2","author":"Gu","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.ejmech.2019.01.007_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2014.08.023","article-title":"Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes","volume":"194","author":"Peddada","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/02656739509022457","article-title":"Extracellular pH distribution in human tumours","volume":"11","author":"Engin","year":"1995","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.ejmech.2019.01.007_bib62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.281.5373.78","article-title":"An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery","volume":"281","author":"Koltover","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.01.007_bib63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0040-6031(94)01884-J","article-title":"Thermal analysis of phase transition behaviour in liposomes","volume":"248","author":"Taylor","year":"1995","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ejmech.2019.01.007_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1166\/jbn.2016.2123","article-title":"Anti-cancer efficacy of paclitaxel loaded in pH triggered liposomes","volume":"12","author":"Jiang","year":"2016","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym10010074","article-title":"Bleomycin-loaded pH-sensitive polymer\u2013lipid-incorporated liposomes for cancer chemotherapy","volume":"10","author":"Yuba","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.ejmech.2019.01.007_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2009.08.022","article-title":"Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors","volume":"141","author":"Manickam","year":"2010","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2017.06.027","article-title":"Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models","volume":"261","author":"Yingying","year":"2017","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib68","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1016\/j.biomaterials.2014.07.059","article-title":"Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2019.01.007_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2019.01.007_bib70","first-page":"211","article-title":"Hyperthermia and liposomes","volume":"15","author":"Kong","year":"1999","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.ejmech.2019.01.007_bib71","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/acsami.5b11619","article-title":"An MMP-2 responsive liposome integrating antifibrosis and chemotherapeutic drugs for enhanced drug perfusion and efficacy in pancreatic cancer","volume":"8","author":"Ji","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejmech.2019.01.007_bib72","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1200\/JCO.1998.16.9.2906","volume":"16","author":"Koops","year":"1998","journal-title":"J.\u00a0Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib73","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/02656739609023525","article-title":"Simulation studies promote technological development of radiofrequency phased array hyperthermia","volume":"12","author":"Wust","year":"1996","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.ejmech.2019.01.007_bib74","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1109\/22.539932","article-title":"Temperature control and thermal dosimetry by microwave radiometry in hyperthermia","volume":"44","author":"Dubois","year":"1996","journal-title":"IEEE. Trans. Microw. Theory. Tech."},{"key":"10.1016\/j.ejmech.2019.01.007_bib75","first-page":"871","article-title":"Ultrasound technology for hyperthermia, Ultrasound","volume":"25","author":"Diederich","year":"1999","journal-title":"Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0360-3016(77)90013-X","article-title":"Hyperthermia and radiation\u2013a selective thermal effect on chronically hypoxic tumor cells in\u00a0vivo","volume":"2","author":"Dewey","year":"1977","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ejmech.2019.01.007_bib78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<137::AID-JCP15>3.0.CO;2-A","article-title":"Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia","volume":"177","author":"Burd","year":"1998","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib79","first-page":"3027","article-title":"Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature","volume":"61","author":"Kong","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.01.007_bib80","article-title":"Preparation and evaluation of Oxaliplatin thermosensitive liposomes with rapid release and high stability","volume":"11","author":"Chunying","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.01.007_bib81","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update, CA","volume":"61","author":"Agostinis","year":"2011","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2019.01.007_bib82","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1158\/1535-7163.MCT-13-0633","article-title":"The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy","volume":"13","author":"Sano","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2019.01.007_bib83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jconrel.2018.06.029","article-title":"The effect of light sensitizer localization on the stability of indocyanine green liposomes","volume":"284","author":"Lajunen","year":"2018","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib84","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194","author":"Gandhi","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2009.09.020","article-title":"Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals","volume":"141","author":"Ying","year":"2010","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199109053251006","article-title":"Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay","volume":"325","author":"Vivo","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.01.007_bib87","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.01.007_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2018.07.055","article-title":"pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma","volume":"124","author":"Man","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib89","first-page":"6615","article-title":"Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes","volume":"10","author":"Gao","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2019.01.007_bib90","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1039\/C4BM00369A","article-title":"Drug and gene co-delivery systems for cancer treatment","volume":"3","author":"Yang","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib91","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.03.031","article-title":"Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks","volume":"149","author":"Lee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.01.007_bib92","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.colsurfb.2016.07.002","article-title":"Thermal and magnetic dual-responsive liposomes with acell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy","volume":"146","author":"Yanfang","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejmech.2019.01.007_bib93","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.bbamem.2016.02.025","article-title":"Rational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their PEGylation","volume":"1858","author":"Bunker","year":"2016","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.ejmech.2019.01.007_bib94","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1124\/pr.115.012070","article-title":"Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come","volume":"68","author":"Yingchoncharoen","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2019.01.007_bib95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/wnan.1288","article-title":"Nanomedicine: a pharma perspective, wires","volume":"7","author":"Brown","year":"2015","journal-title":"Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib96","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.007_bib97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A\u00a0double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"35","author":"Bowden","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.007_bib98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0924-8579(00)00341-1","article-title":"Lipid-based amphotericin B: a review of the last 10 years of use","volume":"17","author":"Hann","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.01.007_bib99","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","article-title":"Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS","volume":"6","author":"James","year":"1994","journal-title":"Clin. Oncol.-UK"},{"key":"10.1016\/j.ejmech.2019.01.007_bib100","first-page":"277","article-title":"Liposomal daunorubicin as treatment for Kaposi's sarcoma","volume":"2","author":"Petre","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2019.01.007_bib101","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.2001.19.5.1444","article-title":"Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer","volume":"19","author":"Batist","year":"2001","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib102","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2019.01.007_bib103","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10637-015-0311-x","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo\u00ae) after intravenous administration in Non-human primates","volume":"34","author":"Shah","year":"2016","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2019.01.007_bib104","series-title":"FDA Approves Onivyde Combo Regimen for Advanced Pancreatic Cancer","author":"DiGiulio","year":"2015"},{"key":"10.1016\/j.ejmech.2019.01.007_bib105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/01.ANE.0000145009.03574.78","article-title":"A\u00a0comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery","volume":"100","author":"Gambling","year":"2005","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2019.01.007_bib106","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1021\/acs.molpharmaceut.5b00967","article-title":"Specially-made lipid-based assemblies for improving transmembrane gene delivery: comparison of basic amino acid residue rich periphery","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.01.007_bib107","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194","author":"Gandhi","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2019.01.007_bib108","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.bbrc.2003.11.057","article-title":"Cationic liposome-mediated delivery of siRNAs in adult mice","volume":"312","author":"Sioud","year":"2003","journal-title":"Biochem. Biophys. Res."},{"key":"10.1016\/j.ejmech.2019.01.007_bib109","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jddst.2018.02.005","article-title":"Development of a novel cationic liposome: evaluation of liposome mediated transfection and anti-proliferative effects of miR-101 in acute myeloid leukemia","volume":"45","author":"Lotfabadi","year":"2018","journal-title":"J.\u00a0Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.aca.2017.11.061","article-title":"Highly sensitive colorimetric aptasensor for ochratoxin A detection based on enzyme-encapsulated liposome","volume":"1002","author":"Cuiying","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejmech.2019.01.007_bib111","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nucmedbio.2016.05.010","article-title":"PEGylated nanoliposomes encapsulating angiogenic peptides improve perfusion defects: radionuclide imaging-based study","volume":"43","author":"Hwang","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib112","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/1357-4310(96)88805-8","article-title":"Liposomes as delivery agents for medical imaging","volume":"2","author":"Torchilin","year":"1996","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.ejmech.2019.01.007_bib113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.01.007_bib114","doi-asserted-by":"crossref","first-page":"32741","DOI":"10.18632\/oncotarget.15642","article-title":"Theranostic imaging of liver cancer using targeted optical\/MRI dual-modal probes","volume":"8","author":"Qingshan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2019.01.007_bib115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2019.01.007_bib116","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib117","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0264-410X(96)00040-0","article-title":"A\u00a0virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans","volume":"14","author":"Cryz","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib118","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.vaccine.2009.05.029","article-title":"Eleven years of Inflexal\u00aeV\u2014a virosomal adjuvanted influenza vaccine","volume":"27","author":"Herzog","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib119","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/14760584.6.5.711","article-title":"Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations","volume":"6","author":"Moser","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejmech.2019.01.007_bib120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(99)00404-1","article-title":"Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes","volume":"18","author":"Arkema","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.2.1.2494","article-title":"Applications of influenza virosomes as a delivery system","volume":"2","author":"Cus","year":"2006","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib122","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0264-410X(02)00103-2","article-title":"Virosome-mediated delivery of protein antigens to dendritic cells","volume":"20","author":"Bungener","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib123","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2005.04.026","article-title":"The virosome concept for influenza vaccines","volume":"23","author":"Huckriede","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib124","first-page":"219","article-title":"Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system","volume":"92","author":"Cryz","year":"1998","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.ejmech.2019.01.007_bib125","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal\u00aeV a trivalent virosome subunit influenza vaccine: production","volume":"20","author":"Mischler","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2019.01.007_bib126","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2008.05.002","article-title":"Liposomes and skin: from drug delivery to model membranes","volume":"34","author":"Maghraby","year":"2008","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2019.01.007_bib127","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.biomaterials.2008.12.013","article-title":"PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery","volume":"30","author":"Chan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2019.01.007_bib128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.matchemphys.2018.01.027","article-title":"Spherical silica hybrid liposome particles with controlled release of citrus unshiu peel extracts","volume":"208","author":"Hyesun","year":"2018","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.ejmech.2019.01.007_bib129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/14728222.2013.740461","article-title":"Cathepsin B as a cancer target","volume":"17","author":"Gondi","year":"2013","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:53:46Z","timestamp":1759326826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419300078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":129,"alternative-id":["S0223523419300078"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.007","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Composition design and medical application of liposomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}